BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang F, Huang P, Shi L, Liu F, Tang A, Xu S. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice. Drug Des Devel Ther 2020;14:3865-74. [PMID: 33061293 DOI: 10.2147/DDDT.S258857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Liang J, Li W, Liu H, Li X, Yuan C, Zou W, Qu L. Di’ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway. Front Pharmacol 2022;13:857092. [DOI: 10.3389/fphar.2022.857092] [Reference Citation Analysis]
2 Mcilwraith EK, Zhang N, Belsham DD. The Regulation of Phoenixin: A Fascinating Multidimensional Peptide. Journal of the Endocrine Society 2022;6:bvab192. [DOI: 10.1210/jendso/bvab192] [Reference Citation Analysis]
3 Breton TS, Murray CA, Huff SR, Phaneuf AM, Tripp BM, Patuel SJ, Martyniuk CJ, Dimaggio MA. Phoenixin-14 alters transcriptome and steroid profiles in female green-spotted puffer (Dichotomyctere nigroviridis). Sci Rep 2022;12. [DOI: 10.1038/s41598-022-13695-z] [Reference Citation Analysis]
4 Billert M, Rak A, Nowak KW, Skrzypski M. Phoenixin: More than Reproductive Peptide. Int J Mol Sci 2020;21:E8378. [PMID: 33171667 DOI: 10.3390/ijms21218378] [Cited by in F6Publishing: 1] [Reference Citation Analysis]